Showing 121-130 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Comprehensive Landscape Study on Biomaterials in T1D | Quaestio Global Partners, LLC | Magdy Abdel-Malik | Cures | 14-March-2025 to 30-June-2025 | $55,000.00 |
| Evaluation of a novel insulin sensitizer on glycemic control, insulin usage, and cardiovascular biomarkers in people with type 1 diabetes who use closed-loop automated insulin delivery | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-August-2025 to 31-July-2028 | $1,031,908.99 |
| Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-December-2022 to 30-November-2025 | $858,072.00 |
| AID pattern search engine for algorithm adaptation informing fully automated closed loop | Rector & Visitors of the University of Virginia | Tobore Igbe | Improving Lives | 01-March-2024 to 28-February-2026 | $66,500.00 |
| ST2 Tregs in enhancing islet transplantation | Rector & Visitors of the University of Virginia | Rahul Sharma | Cures | 01-July-2025 to 30-June-2028 | $499,997.13 |
| Improving prediction of T1D risk by establishing a self-administered CGM-based technology and whole genome-based polygenic risk scores in diverse populations | Rector & Visitors of the University of Virginia | Leon Farhy | Cures | 01-August-2022 to 31-July-2025 | $599,999.66 |
| S1P transport inhibitors for prevention of T1D | Rector & Visitors of the University of Virginia | Kevin Lynch | Cures | 01-October-2024 to 30-September-2026 | $520,627.00 |
| Preclinical Optimization of Polyclonal IgM for Type 1 Diabetes Prevention and Reversal | Rector & Visitors of the University of Virginia | Kenneth Brayman | Cures | 01-July-2024 to 30-June-2025 | $249,500.00 |
| Anti-CD71 immunotherapy to restore T cell homeostasis in autoimmunity | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-September-2025 to 31-August-2026 | $150,000.00 |
| The role of iron metabolism in T cell subsets in type 1 diabetes | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-March-2025 to 28-February-2026 | $110,000.00 |